University of California, San Francisco at ENA 2026

Nov 18–20, 2026 Barcelona, Spain ~1.5k attendees Website

University of California, San Francisco brings 2 presentations to ENA 2026 in Barcelona. Its program spans next-generation CAR T cell therapy and molecular profiling in colorectal cancer. The work ranges from using CRISPR activation and interference to decode CAR T cell function to a neural gene signature that predicts recurrence of resected colorectal cancer liver metastases.

Organization	ENA 2026 Attendance
University of California, San Francisco San Francisco, CA
ucsf.edu Universities & institutes Health sciences university in San Francisco with a comprehensive cancer center and an academic medical center.	Poster Wed Nov 18 12–1:30pm 3:50–4:15pm 5:45–7pm Part of Poster session: Molecular profiling A neural gene signature predicts recurrence of resected colorectal cancer liver metastases Genomics Talk Fri Nov 20 8:20–8:40am Part of Plenary Session 5: Next-generation cell therapies (CAR-T, TCR) Decoding CAR T cell function with CRISPR activation and interference Cell therapy

Instantly find 20 buyers from University of California, San Francisco

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by EORTC, the NCI or the AACR. Submit a correction